David Moore , executive vice president for Novo Nordisk's U.S
GLP-1 receptor agonists in obese patients with inflammatory bowel disease: from molecular mechanisms to clinical considerations and practical recommendations for safe and effective use
Reported / Possible Side Effects Mild, anecdotal: Occasional reports of mild headache, transient jitteriness, or injection-site reactions
Offer discount (and any qualifying grocery purchase where discount is applied) excludes prescription items, prescription co-payments, alcohol, tobacco, fuel, fluid dairy (including dairy substitutes), bus/commuter passes, fishing/hunting licenses and tags, stamps, money orders/transfers, ski/amusement park/event/lottery tickets, phone/gift cards, regulatory fees (e.g